TNFRSF8 and classic Hodgkin lymphoma: To understand which CAR T-cell could be used for the treatment of cHL, and how many cHL patients could receive multiple CAR T-cell therapy, we detected the expression of CD19, CD20, and CD30 in RS cells by IHC staining in 38 paraffin-embedded specimens from patients with cHL.